Investing News NetworkYour trusted source for investing success

biomarin pharmaceutical

BMO Kicks Off Coverage of 4 Biotech Players

Long Way to Go for Gene Therapies, 2018 Outlook Panel Says

BioMarin Announces Several Oral and Poster Presentations

BioMarin Announces EMA Grants Accelerated Assessment for Cerliponase Alfa, Experimental Treatment for a Form of Batten Disease

Top 5 Holdings in PowerShares Dynamic Biotechnology & Genome ETF

BioMarin Provides Program Update on Vosoritide in Achondroplasia

BioMarin Receives European Orphan Drug Designation for BMN 270, First Investigational AAV-Factor VIII Gene Therapy for Patients with Hemophilia A

Ken Bate Joins Vanda Pharmaceuticals' Board of Directors

BioMarin's Cancer Drug Purchased by Medivation for $410 Million Upfront

Sarepta And BioMarin Work Towards an FDA Coupon

Operational Update

Lode Gold Closes $1.51 Million Upsized Private Placement

CORRECTED: CHARBONE Hydrogen is Acquiring Hydrogen Production Assets and Closing a First Tranche of $1M Private Placement Financing

CORRIGE: CHARBONE Hydrogene acquiert des actifs de production d'hydrogene et cloture une premiere tranche d'un financement par placement prive de 1 M$

Purepoint Uranium Closes Final Tranche of $6 Million Private Placement

Locksley Resources

Westport

Alvopetro Energy

Electric Royalties

Saga Metals

Empire Metals

MARKETS

COMMODITIES

CURRENCIES